As a new plant, GarliCare was nurtured by CAPA, finished and started operation in 2023. Covering an area of 26666㎡ and with the presence of offices, R&D centers, production workshops, and warehouses, GarliCare is deemed a biotechnology enterprise. We not only focus on the full use of garlic and ginger but also do research on other food additives and manufacture the plant extract.
| Sales markets | Africa; Asia; Australia; Central/South America; Eastern Europe; North America; Western Europe |
|---|---|
| Affiliated categories: | Flavourings |Garlic |Ginger More |
To proceed please sign up (free buyer account) or log in (if you already have an account).
Log in